BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 229783)

  • 1. Serum antibody levels as risk factors in the dissemination of herpes zoster.
    Mazur MH; Whitley RJ; Dolin R
    Arch Intern Med; 1979 Dec; 139(12):1341-5. PubMed ID: 229783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of varicella-zoster antibody by immune adherence hemagglutination test.
    Kositanont U; Suvatte V; Wasi C; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):342-7. PubMed ID: 6098021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
    Arvin AM; Koropchak CM
    J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement fixing antibody to varicella-zoster virus in different age groups and after zoster.
    Moschen ME; Peserico A; Trivello R
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):70-3. PubMed ID: 193530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon, antibody, and other host factors in herpes zoster.
    Stevens DA; Merigan TC
    J Clin Invest; 1972 May; 51(5):1170-8. PubMed ID: 5020430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
    Onozawa M; Hashino S; Takahata M; Fujisawa F; Kawamura T; Nakagawa M; Kahata K; Kondo T; Ota S; Tanaka J; Imamura M; Asaka M
    J Clin Microbiol; 2006 Dec; 44(12):4441-3. PubMed ID: 17035500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant.
    Christiansen NP; Haake RJ; Hurd DD
    Bone Marrow Transplant; 1991 Jun; 7(6):435-7. PubMed ID: 1873590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
    Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
    Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays.
    Zachar V; Mayer V; Schmidtmayerová H
    Acta Virol; 1988 May; 32(3):243-51. PubMed ID: 2902772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.
    Asano Y; Takahashi M
    Biken J; 1978 Mar; 21(1):15-23. PubMed ID: 208504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.